Events

MEDTRONIC - LEADING THE WAY IN DBS  For the one million people diagnosed with Parkinson's disease in the United States, Medtronic, a global leader in healthcare technology, proudly announces FDA approval of BrainSense™ Adaptive deep brain stimulation (aDBS) and BrainSense™ Electrode Identifier (EI).  Deep brain stimulation (DBS) has been transforming the lives of people with Parkinson's and other neurological disorders for more than 30 years. DBS is similar to a cardiac pacemaker, but for the brain. It uses a surgically implanted neurostimulator via a minimally invasive procedure to transmit electrical signals to specific parts of the brain affected by debilitating neurological disorders. Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology, introducing aDBS for people living with Parkinson's. This feature personalizes therapy based on a patient's brain activity in real time – both in clinical settings and in daily life2. It provides enhanced therapy personalization for symptom control that automatically adjusts, minimizing the need for patients to manually adjust stimulation.  "Medtronic is the only company in the world to offer an adaptive DBS system that dynamically adjusts therapy in real time. This new era in Parkinson's care represents more than a decade of intentional innovation ushering in personalized neuromodulation at scale that responds to a patient's changing needs, equipping […]

Updates in Movement Disorders/Parkinson’s Disease Research at MUSC Our main speaker will be Dr. Christine Cooper. Dr. Cooper is an Associate Professor of Neurology and Movement Disorders specialist at the Medical University of South Carolina (MUSC). At MUSC, she is the director of the department’s Clinical Trials Unit, which focuses on bringing the latest, cutting-edge industry-sponsored research to South Carolina patients. Her own investigator-initiated research focuses on using neuroimaging and non-invasive brain stimulation devices to better understand and investigate Movement Disorders.  Dr. Cooper received her medical degree from the University of Florida with honors in Clinical Research. She went on to complete her neurology residency at Beth Israel Deaconess Medical Center/Harvard University, followed by a fellowship in movement disorders at Pennsylvania Hospital/University of Pennsylvania. Dr. Cooper treats adult patients with Parkinson's disease, tremor, dystonia, dyskinesia, ataxia, tics, and chorea. As part of the treatments offered, Dr. Cooper performs botulinum toxin injections for movement disorders patients with dystonia and hemifacial spasm. She provides pre-surgical evaluations for deep brain stimulation and post-surgical programming for Parkinson's disease, tremor, and dystonia. We will discuss ongoing and upcoming research for Parkinson’s disease and Movement Disorders at MUSC and nationally. Research participation can vary from observational […]